CAS 2419107-09-6

3-Quinolinecarboxylic acid, 5,7-dichloro-4-[[3-[(methylamino)sulfonyl]phenyl]amino]-, ethyl ester

Description:

3-Quinolinecarboxylic acid, 5,7-dichloro-4-[[3-[(methylamino)sulfonyl]phenyl]amino]-, ethyl ester, identified by CAS number 2419107-09-6, is a synthetic organic compound characterized by its complex structure, which includes a quinoline ring system and multiple functional groups. The presence of dichloro substituents at the 5 and 7 positions of the quinoline moiety contributes to its potential biological activity, while the ethyl ester group enhances its lipophilicity, potentially influencing its pharmacokinetic properties. The sulfonamide functionality, linked to a methylamino group, may impart specific interactions with biological targets, making it of interest in medicinal chemistry. This compound may exhibit properties such as antimicrobial or anticancer activity, although specific biological effects would depend on further empirical studies. Its synthesis and characterization would typically involve standard organic chemistry techniques, including purification methods like chromatography. As with many compounds of this nature, safety and handling precautions are essential due to potential toxicity or reactivity associated with the functional groups present.

Formula: C₁₉H₁₇Cl₂N₃O₄S

Synonyms:

• 3-Quinolinecarboxylic acid, 5,7-dichloro-4-[[3-[(methylamino)sulfonyl]phenyl]amino]-, ethyl ester
• Aurora kinase inhibitor-9

Aurora kinase inhibitor-9

CAS: 2419107-09-6

Aurora kinase inhibitor-9 (9d) targets AURKA/B with IC50: 0.093 μM for A and 0.09 μM for B, with wide anti-proliferative effects.

Formula: C₁₉H₁₇Cl₂N₃O₄S

Color and Shape: Solid

Molecular weight: 454.33

Ref: TM-T62789